Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation

Annals of Surgical Oncology

Volumn 17, Issue 9, 2010, Pages 2290-2302

  Vitale, Alessandro ^a   D'Amico, Francesco ^b   Frigo, Anna Chiara ^c   Grigoletto, Francesco ^c   Brolese, Alberto ^b   Zanus, Giacomo ^b   Neri, Daniele ^b   Carraro, Amedeo ^b   D'Amico, Francesco Enrico ^b   Burra, Patrizia ^c   Russo, Francesco ^c   Angeli, Paolo ^c   Cillo, Umberto ^b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INVASION; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HEALTH CARE POLICY; HOSPITAL ADMISSION; HOSPITAL POLICY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR GROWTH;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEALTH PRIORITIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 77956339629     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0993-4     Document Type: Article

References (38)

1. Harper AM, Edwards EB, Eleison MD. The OPTN waiting list, 1988-2000. Clin Transpl. 2001;73-85.
2. JM Llovet J Fuster J Bruix 1999 Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1434 1440 10.1002/hep.510300629 1:STN:280:DC%2BD3c%2Fkt1eiug%3D%3D 10573522
3. FY Yao NM Bass B Nikolai, et al. 2002 Liver transplantation for hepatocellular carcinoma. Analysis of survival according to the intention-to-treat principle, and drop-out from the waiting list Liver Transplant 8 873 883 10.1053/jlts.2002.34923
4. M Malinchoc PS Karnath FD Gordon, et al. 2000 A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 864 871 10.1053/he.2000.5852 1:STN:280:DC%2BD3c7pvVWmtA%3D%3D 10733541
5. RB Freeman Jr 2007 The model for end-stage liver disease comes of age Clin Liver Dis 11 249 263 10.1016/j.cld.2007.04.005 17606205
6. RB Freeman EB Edwards AM Harper 2006 Waiting list removal rates among patients with chronic and malignant liver disease Am J Transplant 6 1416 1421 10.1111/j.1600-6143.2006.01321.x 1:STN:280:DC%2BD283mt1emsA%3D%3D 16686765
7. GN Ioannou JD Perkins RL Carithers 2008 Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival Gastroenterology 134 1342 1351 10.1053/j.gastro.2008.02.013 18471511
8. RTP Poon ST Fan CM Lo CL Liu J Wong 2007 Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation Ann Surg 245 51 58 10.1097/01.sla.0000225255.01668.65 17197965
9. CM Lo ST Fan CL Liu, et al. 2007 Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma Br J Surg 94 78 86 10.1002/bjs.5528 1:STN:280:DC%2BD2s%2Fhs1OktA%3D%3D 17016793
10. RA Fisher LM Kulik CE Freise, et al. 2007 Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation Am J Transplant 7 1601 1608 10.1111/j.1600-6143.2007.01802.x 1:STN:280:DC%2BD2szgtFCgsw%3D%3D 17511683
11. J Bruix M Sherman 2005 Management of hepatocellular carcinoma Hepatology 42 1208 1236 10.1002/hep.20933 16250051
12. FY Yao NM Bass B Nikolai, et al. 2003 A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy Liver Transplant 9 684 692 10.1053/jlts.2003.50147
13. FY Yao NM Bass NL Ascher JP Roberts 2004 Liver transplantation for hepatocellular carcinoma: lessons from the first year under the model of end-stage liver disease (MELD) organ allocation policy Liver Transplant 10 621 630 10.1002/lt.20159
14. S Jonas WO Bechstein T Steinmuller, et al. 2001 Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 1080 1086 10.1053/jhep.2001.23561 1:STN:280:DC%2BD3MzgvFOluw%3D%3D 11343235
15. GB Klintmalm 1998 Liver transplantation for hepatocellular carcinoma: a registry report of the impact of the tumor characteristics on outcome Ann Surg 228 479 490 10.1097/00000658-199810000-00005 1:STN:280:DyaK1M%2FgsV2qug%3D%3D 9790338
16. JW Marsh I Dvorichik M Subotin, et al. 1997 The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study Hepatology 26 444 450 10.1002/hep.510260227 1:STN:280:DyaK2szpsVCguw%3D%3D 9252157
17. IW Graziadei H Sandmueller P Waldenberger, et al. 2003 Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transplant 9 557 563 10.1053/jlts.2003.50106
18. DSK Lu NC Yu SS Raman, et al. 2005 Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation Hepatology 41 1130 1137 10.1002/hep.20688 15841454
19. J Belghiti A Cortes EK Abdalla, et al. 2003 Resection prior to liver transplantation for hepatocellular carcinoma Ann Surg 238 885 892 10.1097/01.sla.0000098621.74851.65 14631225
20. FY Yao M Kinkhabwala JM La Berge, et al. 2005 The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma Am J Transplant 5 795 804 10.1111/j.1600-6143.2005.00750.x 15760404
21. RM Merion DE Schaubel DM Dykstra, et al. 2005 The survival benefit of liver transplantation Am J Transplant 5 307 313 10.1111/j.1600-6143.2004.00703.x 15643990
22. U Cillo A Vitale F Grigoletto, et al. 2007 Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria Am J Transplant 7 972 981 10.1111/j.1600-6143.2006.01719.x 1:STN:280:DC%2BD2s7ptVamsg%3D%3D 17391137
23. U Cillo A Vitale M Bassanello, et al. 2004 Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma Ann Surg 239 150 159 10.1097/01.sla.0000109146.72827.76 14745321
24. U Cillo A Vitale F Grigoletto, et al. 2006 Prospective validation of the Barcelona Clinic Liver Cancer staging system J Hepatol 44 723 731 10.1016/j.jhep.2005.12.015 16488051
25. M Bassanello U Cillo A Vitale, et al. 2003 Multimodal approach and its impact on survival for patients with hepatocellular carcinoma Anticancer Res 23 4047 4054 14666717
26. U Cillo M Bassanello A Vitale, et al. 2004 The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol 40 124 131 10.1016/j.jhep.2003.09.027 14672623
27. A Vitale A Brolese G Zanus, et al. 2005 Multimodal therapy before liver transplantation for hepatocellular carcinoma Hepatol Res 31 112 115 10.1016/j.hepres.2004.12.001 15715997
28. U Cillo A Vitale A Brolese, et al. 2007 Partial hepatectomy as first line treatment of patients with hepatocellular carcinoma J Surg Oncol 95 213 220 10.1002/jso.20641 17066432
29. JO Park SII Lee SY Song, et al. 2003 Measuring response in solid tumors: comparison of RECIST and WHO response criteria Jpn J Clin Oncol 33 533 537 10.1093/jjco/hyg093 14623923
30. J Bruix M Sherman JM Llovet, et al. 2001 Clinical management of hepatocellular carcinoma. Conclusion of the Barcelona-2000 EASL Conference J Hepatol 35 421 430 10.1016/S0168-8278(01)00130-1 1:STN:280: DC%2BD3MrksFCmtg%3D%3D 11592607
31. M Volk JA Marrero 2008 Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Gastroenterology 134 1612 1614 10.1053/j.gastro.2008.03.042 18471530
32. ML Volk S Vijan JA Marrero 2008 A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria Am J Transplant 8 839 846 10.1111/j.1600-6143.2007.02138.x 1:STN:280:DC%2BD1c7mvFajug%3D%3D 18318783
33. V Mazzaferro E Regalia R Doci, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 10.1056/NEJM199603143341104 1:STN:280:DyaK287nsFWltw%3D%3D 8594428
34. PE Majno FP Sarasin G Mentha A Hadengue 2000 Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis Hepatology 31 899 906 10.1053/he.2000.5763 1:STN:280:DC%2BD3c7pvVWlsw%3D%3D 10733546
35. J Belghiti F Durand 2007 Hepatectomy vs. liver transplantation: a combination rather than an opposition Liver Transplant 13 636 638 10.1002/lt.21023
36. G Otto S Herber M Heise, et al. 2006 Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transplant 12 1260 1267 10.1002/lt.20837
37. G Millonig IW Graziadei MC Freund, et al. 2007 Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transplant 13 272 279 10.1002/lt.21033
38. V Mazzaferro JM Llovet R Miceli, et al. 2009 Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 35 43 10.1016/S1470-2045(08)70284-5 19058754